3 Results for "

NCB0846

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NCB0846" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-100830
CAS No.: 1792999-26-8
Purity:  99.61%
Target:  

Wnt MAP4K TGF-beta/Smad

Research Areas:  

Cancer

NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation .
loading...
    loading...
Cat. No.: HY-100830R
CAS No.: 1792999-26-8
Research Areas:  

Cancer

NCB-0846 (Standard) is the analytical standard of NCB-0846 (HY-100830). This product is intended for research and analytical applications. NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation .
loading...
    loading...
Cat. No.: HY-100830A
CAS No.: 2749881-54-5
Target:  

Wnt MAP4K TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

NCB-0970 is the negative control of NCB-0846 (HY-100830). NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation .
loading...
    loading...